ITM Isotope Technologies Munich SE

Unser Unternehmen

As a vertically integrated biotechnology company, we have covered every stage of the radiopharmaceutical process for 20 years: from radioisotope production to developing our own diagnostics and therapeutics. We are also expanding our manufacturing capabilities for novel radioisotopes, advancing our position as a leading global supplier of n.c.a. Lutetium-177 (Lu-177) and Actinium-225 (Ac-225) to deliver the promise of radiopharmaceuticals to patients worldwide.